论文部分内容阅读
本文报告我院１９９３年－１９９５年收治的１１例肺心病呼吸衰竭，应用体外隔肌起博（ｅｘｔｅｒｎ８Ｊｄｉ－ａｐｈｒａ８ｍｐａｃｉｎｇＥＤＰ）临床及实验室综合分析，男９例女２的，年龄５０－7２岁。入院时血气分析ｐＨ７．１５士０．１1氧分压（ＰａＯｚ）８０．５士１４．２二氧化碳在分压（ＰａＯｚ）７８．２士１３．６１碳酸氢根３０．５士６．２ｍｍｏｌ/L；剩余碱５．６３土４．2ｍｍｏｌ/L；入院后除给予吸氧、袂痰，平喘，抗感染等常规治疗外，外用ＥＤＰ。剌激频率中４ＯＨｚ，脉冲宽度０．3ｍｓ；脉冲幅度２０－７5ｖ；剌激时间为一秒；呼吸频率次／分；６０分钟为一疗程。结果１１例右者症状均得到改善。动脉血ＰａＯ２升高１５土４．5ｍｍＨｇ，ｐａＣＯ２平均下降１３．５士３．２ｍｍＨｇ。上述结果表明，ＥＤＰ作为治疗在慢性阻寨性肺疾患呼吸衰竭的一种新方法，具有简单是易行，疗效可靠，易于推广等优越性。
This article reports 11 cases of pneumoconiosis respiratory failure in our hospital from 1993 to 1995. The clinical and laboratory comprehensive analysis of extern8Jdi-aphra8 impacingEDP was performed. There were 9 males and 2 females, aged 50-72 years old. Admission Blood gas analysis pH7.15 ± 0.11 Oxygen partial pressure (PaOz) 80.5 ± 14.2 Carbon dioxide at partial pressure (PaOz) 78.2 ± 13.61 Bicarbonate 30.5 ± 6.2mmol / L ; The remaining alkali 5.63 soil 4.2mmol / L; after admission to give oxygen, Phlegm, antiasthmatic, anti-infection and other conventional treatment, topical EDP. Excitation frequency 4OHz, pulse width 0.3ms; pulse amplitude 20-75v; stimulation time of one second; breathing frequency times / min; 60 minutes for a course of treatment. Results All the 11 cases of right symptoms were improved. Arterial blood PaO2 increased 15 soil 4.5mmHg, paCO2 average decreased 13.5 ± 3.2mmHg. The above results show that EDP as a new treatment for respiratory failure in chronic obstructive pulmonary disease has the advantages of simple and easy to operate, reliable curative effect and easy promotion.